PROVO, Utah – Tute Genomics, the leader in clinical sequencing informatics, today announced the acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commercial advancements in modern human genetics. Knome was co-founded in 2007 by renowned geneticist and Harvard professor George Church, who […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) announced that A. Barry Rand has retired from its board of directors, effective Oct. 31. Rand, 70, was a founding director of Agilent, having served on the board of directors since the company’s spinoff from Hewlett-Packard Co. in 2000. Rand is a highly respected business leader, […]
Redwood City, California, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced enhancements to its QIAGEN Clinical Insight® (QCI™) clinical decision support solution, which streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The QCI bioinformatics platform, launched earlier this year, has been expanded from […]
ST. LOUIS, Mo. and PALO ALTO, Calif. – PierianDx, makers of the leading bioinformatics platform for clinical genomics testing, and Syapse, the leading provider of precision medicine software, announced a partnership that will accelerate the adoption of precision medicine by healthcare systems. The companies will provide functional integration between PierianDx’s Clinical Genomicist WorkstationTM and Syapse […]
Lexington, Mass. –— Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the launch of Simoa 2.0, its next-generation ultrasensitive immunoassay platform. Simoa 2.0 addresses many customer requests and input collected during the rapid growth of Simoa’s first year and a half on […]
RANCHO CORDOVA, Calif. — Cesca Therapeutics Inc.(KOOL), an autologous cell-based regenerative medicine company, today announced that its subsidiary, TotipotentRX, has signed a multi-year distribution agreement with Miltenyi Biotec GmbH (Germany) for clinical product sales throughout India. As part of the agreement, TotipotentRX’s advanced haploidentical transplant program will incorporate Miltenyi Biotec’s CliniMACS(R) Cell Separation System, used […]
SAN RAFAEL, Calif. -– BioCision, LLC, today announced a collaboration with the University of California, San Francisco Transplantation Research Laboratory of Dr. Qizhi Tang, who is researching a novel transplantation immunotherapy that could potentially minimize rates of organ rejection and the toxicity of global immunosuppression; a similar strategy is being investigated for the treatment of […]
FREMONT, Calif. — A new immunoassay for specific detection of hydrocodone has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA). The Thermo Scientific DRI Hydrocodone Assay has the requisite sensitivities to meet the newly proposed Substance Abuse and Mental Health Administration (SAMHSA) guidelines (using a 300 ng/mL cut-off). SAMHSA oversees the […]
Boulder, CO –– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today that they received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices. InDevR achieved ISO 13485:2003 certification following a successful audit of its quality management system and organizational structure by Intertek, a global leader […]
Shenzhen, China — Direct Genomics today announced the GenoCare™ Analyzer, the world’s first single molecule genome sequencer that is being engineered exclusively for the clinic. The GenoCare system improves the cost, speed, and quality of clinical genome sequencing by directly reading a patient’s original DNA or RNA molecules. In contrast to the genome sequencing instruments […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
